MD Anderson News Release 10/29/2015
MD Anderson’s Moon Shots Program, an unprecedented effort and novel organizational model designed to more rapidly convert scientific discoveries into life-saving advances, has expanded its targets, adding several of the most intractable cancers to its campaign.
The innovative program’s transdisciplinary team-science approach now applies to
B-cell lymphoma, glioblastoma (brain cancer...
MD Anderson study shows why protein PTEN causes tumor growth in brain but not in other organs
MD Anderson News Release 10/19/15
Findings encourage practice change for lung cancer management
MD Anderson Cancer Center 10/18/2015
An analysis of...
EphB4 receptor identified as “trigger” for breast and ovarian tumor stimulation
MD Anderson News Release 10/15/2015
Scientists have shown why a drug widely used to treat chemotherapy-induced anemia in ovarian and breast cancer patients also may shorten survival times in some patients by inadvertently stimulating tumor growth.
Anil Sood, M.D., professor of Gynecologic Oncology and Reproductive Medicine at The University...
Trailblazer takes center stage with Tom Brokaw at A Conversation With a Living Legend®
MD Anderson News Release 10/14/15
...
MD Anderson News Release 10/14/2015
Like the film itself, the world premiere of “Until 20” at the Austin Film Festival will be a celebration...
Business and community leaders are committed to advance institution’s efforts to end cancer
MD Anderson News Release 10/09/2015
MD Anderson News Release 10/06/2015
OncoResponse, an immuno-oncology antibody discovery company, has been launched jointly by The...
MD Anderson News Release 10/01/2015
A career-long fascination with discovering the ins and outs of T cells, our immune system’...
RNA editing events another way to investigate biomarkers and therapy targets
MD Anderson News Release 10/01/2015